VEGF 抗体 (AA 27-233)
Quick Overview for VEGF 抗体 (AA 27-233) (ABIN2735205)
抗原
See all VEGF 抗体适用
宿主
克隆类型
标记
应用范围
克隆位点
-
-
抗原表位
- AA 27-233
-
纯化方法
- Purified from mouse ascites fluids by affinity chromatography
-
免疫原
- Human recombinant protein fragment corresponding to amino acids 27-233 of human VEGFA (NP_003367) produced in E.coli.
-
亚型
- IgG2b
-
-
-
-
应用备注
- WB 1:2500~5000, IHC: 1:50-1:150,
-
说明
-
The concentration of the product may vary between diferrent lots.
-
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 0.5-1.0 mg/mL
-
缓冲液
- PBS ( pH 7.3) containing 1 % BSA, 50 % glycerol and 0.02 % sodium azide.
-
储存液
- Sodium azide
-
注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
-
-
: "ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling." in: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Vol. 44, Issue 4, pp. 1370-1380, (2018) (PubMed).
: "The 3p14.2 tumour suppressor ADAMTS9 is inactivated by promoter CpG methylation and inhibits tumour cell growth in breast cancer." in: Journal of cellular and molecular medicine, Vol. 22, Issue 2, pp. 1257-1271, (2018) (PubMed).
-
: "ADAMTS9 is Silenced by Epigenetic Disruption in Colorectal Cancer and Inhibits Cell Growth and Metastasis by Regulating Akt/p53 Signaling." in: Cellular physiology and biochemistry : international journal of experimental cellular physiology, biochemistry, and pharmacology, Vol. 44, Issue 4, pp. 1370-1380, (2018) (PubMed).
-
- VEGF (Vascular Endothelial Growth Factor (VEGF))
-
别名
- VEGF
-
分子量
- 23.8 kDa
-
基因ID
- 7422
-
NCBI登录号
- NM_001025366
-
HGNC
- 7422
抗原
-